Occlutech files for invalidation of AGA Medical`s European patent in UK

Jena, (ANTARA News/PRNewswire-AsiaNet) - Occlutech GmbH, the leading
European manufacturer of cardiac occlusion devices such as ASD, PFO and
LAA occluders today announced that it has initiated invalidation
proceedings against AGA's European patent in the U.K.



Most of the broader claims interpreted into this patent by AGA Medical
were not accepted by the examiners of the European Patent Office in the
original patent approval process due to the existence of prior art.
This creates a significant and justified basis for Occlutech to file
for invalidation.
More at antara.co.id